venBio Global Strategic Fund II L.P.

Entity
Company
Business address
1700 Owens Street, Suite 595, 94158 San Francisco, CA
Phone
415-522-0100
State of incorporation
Cayman Islands
Fiscal year end
December 31
Insider ownership signature
venBio Global Strategic Fund II, L.P., by: venBio Global Strategic GP II, L.P., its general partner, by: venBio Global Strategic GP II, Ltd., its general partner, by: /s/ David Pezeshki, as attorney-in-fact
All SEC filings
View on sec.gov
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
venBio Global Strategic Fund II L.P. has filed 56 SEC EDGAR filings since 3/19/2015

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
SC 13D/A Open Document Open Filing SC 13D/A Sep 15, 2022
SC 13G/A Open Document Open Filing SC 13G/A Jun 7, 2022
4 Open Document Open Filing FORM 4 May 17, 2022 May 13, 2022 001-39425
4 Open Document Open Filing FORM 4 May 12, 2022 May 10, 2022 001-39425
4 Open Document Open Filing FORM 4 May 9, 2022 May 5, 2022 001-39425
SC 13G/A Open Document Open Filing SC 13G/A May 5, 2022
4 Open Document Open Filing FORM 4 May 4, 2022 May 2, 2022 001-39425
4 Open Document Open Filing FORM 4 Apr 29, 2022 Apr 27, 2022 001-39425
4 Open Document Open Filing FORM 4 Apr 26, 2022 Apr 22, 2022 001-39425
4 Open Document Open Filing FORM 4 Apr 21, 2022 Apr 19, 2022 001-39425
SC 13G/A Open Document Open Filing Feb 14, 2022
SC 13D/A Open Document Open Filing SC 13D/A May 7, 2021
SC 13G Open Document Open Filing SC 13G May 7, 2021
4 Open Document Open Filing Apr 29, 2021 Apr 27, 2021 001-40353
4 Open Document Open Filing Apr 26, 2021 Apr 22, 2021 001-40353
3 Open Document Open Filing Apr 22, 2021 Apr 22, 2021 001-40353
SC 13G Open Document Open Filing Feb 16, 2021
SC 13G Open Document Open Filing Oct 6, 2020
SC 13D Open Document Open Filing Oct 1, 2020
SC 13D/A Open Document Open Filing Sep 9, 2020
4 Open Document Open Filing Aug 12, 2020 Aug 11, 2020 001-39425
3 Open Document Open Filing Aug 6, 2020 Aug 6, 2020 001-39425
4 Open Document Open Filing Jul 21, 2020 Jul 21, 2020 001-39386
3 Open Document Open Filing Jul 16, 2020 Jul 16, 2020 001-39386
4 Open Document Open Filing Jul 6, 2020 Jul 1, 2020 001-38944
SC 13D/A Open Document Open Filing Apr 16, 2020
4 Open Document Open Filing PRIMARY DOCUMENT Mar 6, 2020 Mar 4, 2020 001-38944
4 Open Document Open Filing PRIMARY DOCUMENT Mar 3, 2020 Feb 28, 2020 001-38944
4 Open Document Open Filing PRIMARY DOCUMENT Feb 27, 2020 Feb 25, 2020 001-38944
4 Open Document Open Filing PRIMARY DOCUMENT Feb 12, 2020 Feb 11, 2020 001-38944
4 Open Document Open Filing PRIMARY DOCUMENT Feb 10, 2020 Feb 6, 2020 001-38944
4 Open Document Open Filing PRIMARY DOCUMENT Feb 6, 2020 Feb 4, 2020 001-38944
SC 13D/A Open Document Open Filing SC 13D/A Jan 15, 2020
4 Open Document Open Filing PRIMARY DOCUMENT Jan 14, 2020 Jan 13, 2020 001-38944
4 Open Document Open Filing PRIMARY DOCUMENT Jan 10, 2020 Jan 8, 2020 001-38944
4 Open Document Open Filing PRIMARY DOCUMENT Jan 8, 2020 Jan 6, 2020 001-38944
4 Open Document Open Filing PRIMARY DOCUMENT Jan 6, 2020 Jan 2, 2020 001-38944
4 Open Document Open Filing PRIMARY DOCUMENT Jan 3, 2020 Dec 31, 2019 001-38944
SC 13D Open Document Open Filing SC 13D Jun 26, 2019
4 Open Document Open Filing PRIMARY DOCUMENT Jun 25, 2019 Jun 24, 2019 001-38944
3 Open Document Open Filing PRIMARY DOCUMENT Jun 19, 2019 Jun 19, 2019 001-38944
SC 13G/A Open Document Open Filing VENBIO GLOBAL STRATEGIC FUND II, L.P. / APELLIS PHARMACEUTICALS - SCHEDULE 13G/A Feb 14, 2019
SC 13G/A Open Document Open Filing VENBIO GLOBAL STRATEGIC FUND II, L.P. / NABRIVA THERAPEUTICS AG - SCHEDULE 13G/A Feb 14, 2019
SC 13G Open Document Open Filing VENBIO GLOBAL STRATEGIC FUND II, L.P. / APELLIS PHARMACEUTICALS - SCHEDULE 13G Feb 9, 2018
SC 13G/A Open Document Open Filing VENBIO GLOBAL STRATEGIC FUND II, L.P. / NABRIVA THERAPEUTICS AG - SCHEDULE 13GA Feb 9, 2018
SC 13D Open Document Open Filing VENBIO GLOBAL STRATEGIC FUND II, L.P. - MENLO THERAPEUTICS INC. -- SCHEDULE 13D Feb 8, 2018
4 Open Document Open Filing FORM 4 SUBMISSION Jan 29, 2018 Jan 25, 2018 001-38356
3 Open Document Open Filing FORM 3 SUBMISSION Jan 24, 2018 Jan 24, 2018 001-38356
4 Open Document Open Filing FORM 4 SUBMISSION Nov 13, 2017 Nov 13, 2017 001-38276
3 Open Document Open Filing FORM 3 SUBMISSION Nov 8, 2017 Nov 8, 2017 001-38276
SC 13G Open Document Open Filing VERONA PHARMA PLC - SCHEDULE 13G May 8, 2017
D/A Open Document Open Filing Mar 2, 2017 021-236281
SC 13G/A Open Document Open Filing NABRIVA THERAPEUTICS AG - SCHEDULE 13GA (AMEND. #1) Feb 13, 2017
SC 13G Open Document Open Filing Apr 29, 2016
D/A Open Document Open Filing Mar 18, 2016 021-236281
D Open Document Open Filing Mar 19, 2015 021-236281